BACKGROUND: Recent studies have identified a polymorphism in the endothelin-converting enzyme (ECE)-1b promoter (-338C/A) that is strongly associated with hypertension in women. The polymorphism is located in a consensus binding sequence for the E2F family of transcription factors. E2F proteins are crucially involved in cell-cycle regulation, but their roles in cardiovascular function are poorly understood. Here, we investigated the potential role of E2F2 in blood pressure regulation. METHODS AND RESULTS: Tail-cuff measurements of systolic and diastolic blood pressures were significantly higher in E2F2-null (E2F2(-/-)) mice than in their wild-type littermates, and in ex vivo ring assays, aortas from the E2F2(-/-) mice exhibited significantly greater contractility in response to big endothelin-1. Big endothelin-1 is activated by ECE-1, and mRNA levels of ECE-1b, the repressive ECE-1 isoform, were significantly lower in E2F2(-/-) mice than in wild-type mice. In endothelial cells, chromatin immunoprecipitation assays confirmed that E2F2 binds the ECE-1b promoter, and promoter-reporter assays indicated that E2F2 activates ECE-1b transcription. Furthermore, loss or downregulation of E2F2 led to a decline in ECE-1b levels, to higher levels of the membranous ECE-1 isoforms (ie, ECE-1a, -1c, and -1d), and to deregulated ECE-1 activity. Finally, Sam68 coimmunoprecipitated with E2F2, occupied the ECE-1b promoter (chromatin immunoprecipitation), and repressed E2F2-mediated ECE-1b promoter activity (promoter-reporter assays). CONCLUSIONS: Our results identify a cell-cycle-independent mechanism by which E2F2 regulates endothelial function, arterial contractility, and blood pressure.
BACKGROUND: Recent studies have identified a polymorphism in the endothelin-converting enzyme (ECE)-1b promoter (-338C/A) that is strongly associated with hypertension in women. The polymorphism is located in a consensus binding sequence for the E2F family of transcription factors. E2F proteins are crucially involved in cell-cycle regulation, but their roles in cardiovascular function are poorly understood. Here, we investigated the potential role of E2F2 in blood pressure regulation. METHODS AND RESULTS: Tail-cuff measurements of systolic and diastolic blood pressures were significantly higher in E2F2-null (E2F2(-/-)) mice than in their wild-type littermates, and in ex vivo ring assays, aortas from the E2F2(-/-) mice exhibited significantly greater contractility in response to big endothelin-1. Big endothelin-1 is activated by ECE-1, and mRNA levels of ECE-1b, the repressive ECE-1 isoform, were significantly lower in E2F2(-/-) mice than in wild-type mice. In endothelial cells, chromatin immunoprecipitation assays confirmed that E2F2 binds the ECE-1b promoter, and promoter-reporter assays indicated that E2F2 activates ECE-1b transcription. Furthermore, loss or downregulation of E2F2 led to a decline in ECE-1b levels, to higher levels of the membranous ECE-1 isoforms (ie, ECE-1a, -1c, and -1d), and to deregulated ECE-1 activity. Finally, Sam68 coimmunoprecipitated with E2F2, occupied the ECE-1b promoter (chromatin immunoprecipitation), and repressed E2F2-mediated ECE-1b promoter activity (promoter-reporter assays). CONCLUSIONS: Our results identify a cell-cycle-independent mechanism by which E2F2 regulates endothelial function, arterial contractility, and blood pressure.
Authors: H Müller; A P Bracken; R Vernell; M C Moroni; F Christians; E Grassilli; E Prosperini; E Vigo; J D Oliner; K Helin Journal: Genes Dev Date: 2001-02-01 Impact factor: 11.361
Authors: L Wu; C Timmers; B Maiti; H I Saavedra; L Sang; G T Chong; F Nuckolls; P Giangrande; F A Wright; S J Field; M E Greenberg; S Orkin; J R Nevins; M L Robinson; G Leone Journal: Nature Date: 2001-11-22 Impact factor: 49.962
Authors: M Murga; O Fernández-Capetillo; S J Field; B Moreno; L R Borlado; Y Fujiwara; D Balomenos; A Vicario; A C Carrera; S H Orkin; M E Greenberg; A M Zubiaga Journal: Immunity Date: 2001-12 Impact factor: 31.745
Authors: Julie Wells; Carrie R Graveel; Stephanie M Bartley; Steven J Madore; Peggy J Farnham Journal: Proc Natl Acad Sci U S A Date: 2002-03-19 Impact factor: 11.205
Authors: Minjie Feng; Steven Whitesall; Yunyu Zhang; Martin Beibel; Louis D'Alecy; Keith DiPetrillo Journal: Am J Hypertens Date: 2008-10-09 Impact factor: 2.689
Authors: Yan Zhu; Zhao Bian; Ping Lu; Richard H Karas; Lin Bao; Daniel Cox; Jeffrey Hodgin; Philip W Shaul; Peter Thoren; Oliver Smithies; Jan-Ake Gustafsson; Michael E Mendelsohn Journal: Science Date: 2002-01-18 Impact factor: 47.728
Authors: Min Wu; Junlan Zhou; Min Cheng; Chan Boriboun; Dauren Biyashev; Hong Wang; Alexander Mackie; Tina Thorne; Jonathan Chou; Yiping Wu; Zhishui Chen; Qinghua Liu; Hongbin Yan; Ya Yang; Chunfa Jie; Yao-Liang Tang; Ting C Zhao; Robert N Taylor; Raj Kishore; Douglas W Losordo; Gangjian Qin Journal: Cardiovasc Res Date: 2014-10-23 Impact factor: 10.787
Authors: Min Cheng; Junlan Zhou; Min Wu; Chan Boriboun; Tina Thorne; Ting Liu; Zhifu Xiang; Qiutang Zeng; Toshikazu Tanaka; Yao Liang Tang; Raj Kishore; Michael H Tomasson; Richard J Miller; Douglas W Losordo; Gangjian Qin Journal: Circ Res Date: 2010-09-16 Impact factor: 17.367
Authors: Junlan Zhou; Min Cheng; Yu-Hua Liao; Yu Hu; Min Wu; Qing Wang; Bo Qin; Hong Wang; Yan Zhu; Xiu-Mei Gao; David Goukassian; Ting C Zhao; Yao-Liang Tang; Raj Kishore; Gangjian Qin Journal: PLoS One Date: 2013-05-21 Impact factor: 3.240